Increasing CRC Screening in Community Health Centers Through Mobile Messaging Optimization
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Gina Kruse, MD
University of Colorado, Denver
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
Kasisomayajula Viswanath, PhD - Massachusetts General Hospital
Boston, Massachusetts, United States
Adjoa Anyane-Yeboa, MD, MPH - the Massachusetts League of Community Health Center, Inc.
Boston, Massachusetts, United States
Susan Dargon-Hart - University of Texas Southwestern Medical Center
Dallas, Texas, United States
Lynn Ibekwe-Agunanna, MPH, PhD
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2026
- Primary completion
- 31 Oct 2031
- Completion
- 31 Jan 2032
- Last update posted
- 10 Jul 2026
- Registered enrollment
- 7,220
- Registry id
- NCT07569250
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.